Oncogenetic tree modeling of human hepatocarcinogenesis

International Journal of Cancer

Volumn 130, Issue 3, 2012, Pages 575-583

  Longerich, Thomas ^a   Mueller, Michael Martin ^a   Breuhahn, Kai ^a   Schirmacher, Peter ^a   Benner, Axel ^b   Heiss, Christiane ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

chromosomal instability; hepatocellular carcinoma; oncomodel

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME XQ; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; GENE IDENTIFICATION; GENETIC GAIN; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MUTATION; ONCOGENE; ONCOGENETIC TREE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; GENOMIC INSTABILITY; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MODELS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 82255175201     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26063     Document Type: Article

References (44)

1. Bosch FX, Ribes J, Diaz M, Cleries R,. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16. (Pubitemid 39423365)
2. Kern MA, Breuhahn K, Schirmacher P,. Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res 2002; 86: 67-112.
3. Badvie S,. Hepatocellular carcinoma. Postgrad Med J 2000; 76: 4-11. (Pubitemid 30055017)
4. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M,. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-40. (Pubitemid 34747534)
5. Luber B, Arnold N, Sturzl M, Hohne M, Schirmacher P, Lauer U, Wienberg J, Hofschneider PH, Kekule AS,. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene 1996; 12: 1597-608. (Pubitemid 26146283)
6. Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R,. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457-61.
7. Koike K,. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 1995; 38: 134-42. (Pubitemid 26009384)
8. Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M,. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997; 71: 8856-9. (Pubitemid 27446471)
9. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K,. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-7. (Pubitemid 28417341)
10. Schlaeger* C, Longerich* T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, Ehemann V, Eils R, Lichter P, Schirmacher P, Radlwimmer B,. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008; 47: 511-20. (Pubitemid 351280719)
11. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Sole M, Tovar V, Alsinet C, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008; 68: 6779-88.
12. Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H,. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000; 60: 6503-9.
13. Simon R, Desper R, Papadimitriou CH, Peng A, Alberts DS, Taetle R, Trent JM, Schaffer AA,. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis. Gene Chromosome Cancer 2000; 28: 106-20. (Pubitemid 30176769)
14. Rieker RJ, Penzel R, Aulmann S, Blaeker H, Morresi-Hauf A, Hecker E, Otto HF, Mechtersheimer G, von Heydebreck A,. Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymus. Cancer Genet Cytogenet 2005; 158: 75-80. (Pubitemid 40354329)
15. Desper R, Jiang F, Kallioniemi OP, Moch H, Papadimitriou CH, Schaffer AA,. Distance-based reconstruction of tree models for oncogenesis. J Comput Biol 2000; 7: 789-803.
16. von Heydebreck A, Gunawan B, Fuzesi L,. Maximum likelihood estimation of oncogenetic tree models. Biostatistics 2004; 5: 545-56. (Pubitemid 41180204)
17. Felsenstein J,. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39: 783-91.
18. Beerenwinkel N, Eriksson N, Sturmfels B,. Conjunctive Bayesian networks. Bernoulli 2007; 13: 893-909.
19. Beerenwinkel N, Sullivant S,. Markov models for accumulating mutations. Biometrika 2009; 96: 645-61.
20. Szabo A, Boucher K,. Estimating an oncogenetic tree when false negatives and positives are present. Math Biosci 2002; 176: 219-36. (Pubitemid 34311095)
21. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing 2010.
22. International Working Party. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995; 22: 983-93.
23. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-64.
24. Wilkens L, Flemming P, Gebel M, Bleck J, Terkamp C, Wingen L, Kreipe H, Schlegelberger B,. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci USA 2004; 101: 1309-14. (Pubitemid 38182685)
25. Wong N, Lai P, Pang E, Leung TW, Lau JW, Johnson PJ,. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 2000; 32: 1060-8.
26. Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, Choi JY, Park WS, Kwon MS, Fiegler H, Carter NP, Rhyu MG, et al. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 2008; 123: 2808-15.
27. Patil MA, Gutgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005; 26: 2050-7. (Pubitemid 41672192)
28. Hino O, Tabata S, Hotta Y,. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. Proc Natl Acad Sci USA 1991; 88: 9248-52. (Pubitemid 21915608)
29. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot P,. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005; 54: 1162-8. (Pubitemid 41025914)
30. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, Ma F, Huang W, Yu L, Yue W, Wang Z, Li P, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010.
31. Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P,. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis. Br J Cancer 2005; 92: 935-41. (Pubitemid 40462642)
32. Paterlini P, Brechot C,. The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer. Dig Dis Sci 1991; 36: 1122-9.
33. Brechot C, Kremsdorf D, Paterlini P, Thiers V,. Hepatitis B virus DNA in HBsAg-negative patients. Molecular characterization and clinical implications. J Hepatol 1991; 13 (Suppl 4): S49-S55.
34. Yang J, Qin LX, Ye SL, Liu YK, Li Y, Gao DM, Chen J, Tang ZY,. The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential. J Cancer Res Clin Oncol 2003; 129: 303-8. (Pubitemid 36791686)
35. Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S,. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6791-4.
36. Matsuo K, Satoh S, Okabe H, Nomura A, Maeda T, Yamaoka Y, Ikai I,. SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas. Gene Chromosome Cancer 2003; 36: 283-91. (Pubitemid 36158201)
37. Koyama M, Nagai H, Bando K, Ito M, Moriyama Y, Emi M,. Localization of a target region of allelic loss to a 1-cM interval on chromosome 16p.13.13 in hepatocellular carcinoma. Jpn J Cancer Res 1999; 90: 951-6. (Pubitemid 29500433)
38. Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM,. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer 2004; 91: 753-9. (Pubitemid 39141636)
39. Edmondson HA, Steiner PE,. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
40. Ishak KG, Goodman ZD, Stocker JT,. Hepatocellular carcinoma. In:, Ishak KG, Goodman, ZD, Stocker, JT,. Tumors of the liver and intrahepatic bile ducts. AFIP Atlas of tumor pathology, series III. Washington: Armed Forces Institute of Pathology, 2001. 199-230.
41. Zhang H, Ma H, Wang Q, Chen M, Weng D, Wang H, Zhou J, Li Y, Sun J, Chen Y, Liang X, Zhao J, et al. Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. Oncol Rep 2010; 23: 445-55.
42. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P,. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 2001; 85: 697-704. (Pubitemid 32929468)
43. Murakami Y, Hayashi K, Hirohashi S, Sekiya T,. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991; 51: 5520-5.
44. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, Jou YS,. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 2007; 35: D727-31.